A pilot study on temporal changes in IL-1β and TNF-α serum levels after spinal cord injury: the serum level of TNF-α in acute SCI patients as a possible marker for neurological remission

Serum levels of interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) were measured over a 12-week period in 23 patients with spinal cord injury (SCI) with and without neurological improvement.

Saved in:
Bibliographic Details
Main Authors: Biglari, Bahram (Author) , Swing, T. (Author) , Child, Christopher (Author) , Büchler, Axel (Author) , Westhauser, Fabian (Author) , Bruckner, Thomas (Author) , Ferbert, Thomas (Author) , Gerner, Hans-Jürgen (Author) , Moghaddam-Alvandi, Arash (Author)
Format: Article (Journal)
Language:English
Published: 10 March 2015
In: Spinal cord
Year: 2015, Volume: 53, Issue: 7, Pages: 510-514
ISSN:1476-5624
DOI:10.1038/sc.2015.28
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sc.2015.28
Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/sc201528
Get full text
Author Notes:B. Biglari, T. Swing, C. Child, A. Büchler, F. Westhauser, T. Bruckner, T. Ferbert, H. Jürgen Gerner and A. Moghaddam
Description
Summary:Serum levels of interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) were measured over a 12-week period in 23 patients with spinal cord injury (SCI) with and without neurological improvement.
Item Description:Gesehen am 25.05.2020
Physical Description:Online Resource
ISSN:1476-5624
DOI:10.1038/sc.2015.28